Abstract
In general, there are two types of animal models: natural and experimental. Because there are no natural models for pulmonary fibrosis, an experimental model that reproduces key aspects of the human disease would be useful for the study of this form of lung disease, the natural history of which is not always known. To date, a variety of animal models have been used to investigate mechanisms of pulmonary and other types of fibrosis, including the intratracheal instillation of bleomycin, fluorescein isothiocyanate, or particulate matter, such as silica and asbestos. This chapter will describe two commonly used techniques, namely bleomycin and silica-induced, which have been developed for the study of pulmonary fibrosis in animal models.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Hiwatari, N., Shimura, S., Sasaki, T., et al. (1991) Prognosis of idiopathic pulmonary fibrosis in-patients with mucous hypersecretion. Am. Rev. Respir. Dis. 143, 182–185.
Mannino, D. M., Etzel, R. A., and Parrish, R. G. (1996) Pulmonary fibrosis deaths in the United States, 1979–1991; an analysis of multiple-cause mortality data. Am. J. Respir. Crit. Care Med. 153, 1548–1552.
Gross, T. J. and Hunninghake, G. W. (2001) Idiopathic pulmonary fibrosis. N. Engl. J. Med. 345, 517–525.
Piguet, P.F., Collart, M. A., Grau, G. E., Sappino, A. P., and Vassalli, P. (1990) Requirement of tumor necrosis factor for development of silica-induced pulmonary fibrosis. Nature 344, 245–247.
Gharaee-Kermani, M. and Phan, S. H. (2001) Role of cytokines and cytokine therapy in wound healing and fibrotic diseases. Curr. Pharm. Des 7, 1083–1103.
Gharaee-Kermani, M., Nozaki, Y., Hatano, K., and Phan, S. H. (2001) Lung interlukin-4 gene expression in a murine model of bleomycin-induced pulmonary fibrosis. Cytokine. 5, 138–147.
Huaux, F., Liu, T., McGarry, B., Ullenbruch, M., and Phan, S. H. (2003) Dual roles of interleukin-4 (IL-4) in lung injury and fibrosis. J. Immunol. 170, 2083–2092.
Gharaee-Kermani, M. and Phan, S. H. (1997) Lung Interleukin-5 expression in murine bleomycin-induced pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 16, 438–447.
Zhang, K., Gharaee-Kermani, M., McGarry, B., and Phan, S. H. (1994) In situ hybridization analysis of rat lung al (I), and a2 (I) collagen gene expression in pulmonary fibrosis induced by endotracheal bleomycin injection. Lab. Invest. 70, 192–202.
Zhang, K., Gharaee-Kermani, M., Jones, M. L., Warren, J. S., and Phan, S. H. (1994) Lung monocyte chemoattractant protein-1 gene expression in bleomycininduced pulmonary fibrosis. J. Immunol. 153, 4733–4741.
Zhang, K., Gharaee-Kermani, M., McGarry, B., Remick, D., and Phan, S. H. (1997) TNF-a mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis. J. Immunol. 158, 954–959.
Zhang, K., Flanders, K. C., and Phan, S. H. (1995) Cellular localization of transforming growth factor-b expression in bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 147, 352–361
Gharaee-Kermani, M., McCullumsmith R. E., Charo, I. F., Kunkel, S. L., and Phan, S. H. (2003) CC-Chemokine receptor 2 required for bleomycin-induced pulmonary fibrosis. Cytokine 24, 266–276.
Gharaee-Kermani, M., McGarry, B., Lukacs, N., Huffnagle, G., Egan, R. W., and Phan, S. H. (1998) The role of IL-5 in bleomycin-induced pulmonary fibrosis. J. Leukocyte Biol. 64, 657–666.
Barbarin, V., Arras, M., Misson, P., et al. (2004) Characterization of the effect of interleukin-10 on silica-induced lung fibrosis in mice. Am. J. Respir. Cell Mol. Biol. 31, 78–85.
Kolodsick, J. E., Toews, G. T., Jakubzick, C., et al. (2004) Protection from fluorescein isothiocyanate-induced fibrosis in IL-13 deficient, mice results from impaired collagen synthesis by fibroblasts. J. Immunol. 172, 4068–4076.
Kelley, J., Newman, R. A., and Evans, J. N. (1980) Bleomycin-induced pulmonary fibrosis in the rat. Prevention with an inhibitor of collagen synthesis. J. Lab. Clin. Med. 96, 954–964.
Reid, L. M. (1980) needs for animal models of human diseases of the respiratory system. Am. J. Pathol. 101(3), S 89–101.
Coin, P. G., Osornio-Vargas, A. R., Roggli, V. L., and Brody, A. R. (1996) Pulmonary fibrogenesis after three consecutive inhalation exposures to chrysotile asbestos. Am. J. Respir. Crit Care Med. 154, 1511–1519.
Karvonen, R. L., Fernandez-Madrid, F., Maughan, R. L., Palmer, K. C., and Fernandez-Madrid, I. (1987) An animal model of pulmonary radiation fibrosis with biochemical, physiologic, immunologic, and morphologic observations. Radiat. Res. 111, 68–80.
Last, J. A., Gelzleicher, T. R., Pinkerton, K, E., Walker, R. M., and Witschi, H. (1993) A new model of progressive pulmonary fibrosis in rars. Am. Rev. Respir. Dis. 111, 68–80.
Hashimoto, N., Jin, H., Liu, T., Chensue, S. W., and Phan, S. H. (2004) Bone marrow-derived progenitor cells in pulmonary fibrosis. J. Clin. Invest. 113, 243–252.
Park, S-H., Saleh, D., Giaid, A., Michel, R. P. (1997) Increased endothelin-1 in bleomycin-induced pulmonary fibrosis and the effect of an endothelin receptor antagonist. Am. J. Respir. Crit Care Med. 156, 600–608.
Umeda, Y., Marui, T., Matsuno, Y., et al. (2004) Skeletal muscle targeting in vivo electroporation-mediated HGF gene therapy of bleomycin-induced pulmonary fibrosis in Mice. Lab. Invest. 84, 836–844.
Gharaee-Kermani, M. and Phan, S. H. (2004) Role of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis, in Pulmonary Fibrosis (Lynch, J. P., ed.) Dekker, New York: pp. 509–563.
Huaux, F., Louahed, J., Hudspith, B., Meredith, C., Delos, M., Renauld, J.-C., and Lison, D. (1998) Role of interleukin-10 in the lung response to silica in mice. Am. J. Respir. Cell. Mol Biol. 18, 51–59.
Huaux, F., Liu, T., McGarry, B., Ullenbruch, M., Xing, Z., Phan, S. H. (2003) Eosinophils and T lymphocytes possess distinct roles in bleomycin-induced lung injury and fibrosis. J. Immunol. 171, 5470–5481.
Feischmann, R. W., Barber, J. R., Thompson, G. R., et al. (1971) Bleomycin induced interstitial pneumonia in dogs. Thorax. 26, 675–682.
Adamson, I. Y. R. and Bowden, D. H. (1974) The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am. J. Pathol. 77, 185–190.
McCullough, B., Collins, J. F., Johanson, W, G., and Grover, F. L. (1978) Bleomycin induced diffuse interstitial pulmonary fibrosis in baboons. J. Clin. Invest. 61, 79–88.
Harrison, J. H. and Lazo, J. S. (1987) High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis. J. Pharmacol. Exp. Ther. 243, 1185–1194.
Acknowledgments
This work was supported in part by the American Lung Association of Michigan (grant to MG-K) and by National Institutes of Health grants HL28737, HL31963, HL52285, and HL 77297 (to SHP).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc.
About this protocol
Cite this protocol
Gharaee-Kermani, M., Ullenbruch, M., Phan, S.H. (2005). Animal Models of Pulmonary Fibrosis. In: Varga, J., Brenner, D.A., Phan, S.H. (eds) Fibrosis Research. Methods in Molecular Medicine, vol 117. Humana Press. https://doi.org/10.1385/1-59259-940-0:251
Download citation
DOI: https://doi.org/10.1385/1-59259-940-0:251
Publisher Name: Humana Press
Print ISBN: 978-1-58829-479-1
Online ISBN: 978-1-59259-940-0
eBook Packages: Springer Protocols